|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1801100403 |
| 003 |
DE-627 |
| 005 |
20250619202118.0 |
| 007 |
tu |
| 008 |
220506s2022 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1801100403
|
| 035 |
|
|
|a (DE-599)KXP1801100403
|
| 035 |
|
|
|a (OCoLC)1314279044
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
4 |
|a 610
|a 540
|q DE-101
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 30
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 44.41
|2 bkl
|
| 100 |
1 |
|
|a Löcherer, Christian
|d 1990-
|e VerfasserIn
|0 (DE-588)125695120X
|0 (DE-627)1801100055
|4 aut
|
| 245 |
1 |
0 |
|a CoA precursors and their analogs for the treatment of genetic disorders and as 5´-end modification of RNA
|c presented by Apotheker Christian Löcherer ; referees: Prof. Dr. Andres Jäschke, Prof. Dr. Dr. Stoecklin
|
| 264 |
|
1 |
|a Heidelberg
|c [2022]
|
| 300 |
|
|
|a [12], 146 Seiten
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a References: Seite 132-141
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-University Heidelberg
|d 2022
|
| 546 |
|
|
|a Text Englisch, Zusammenfassung in englischer und deutscher Sprache
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|c 20250619
|f FID
|f DE-2298
|x XA-DE-NI
|z FID Pharmazie
|2 pdager
|5 DE-84
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 689 |
0 |
0 |
|d s
|0 (DE-588)4143176-5
|0 (DE-627)104408812
|0 (DE-576)209724234
|a Arzneimittelentwicklung
|2 gnd
|
| 689 |
0 |
1 |
|d s
|0 (DE-588)4148201-3
|0 (DE-627)105570796
|0 (DE-576)209762675
|a Coenzym
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Jäschke, Andres
|d 1962-
|e AkademischeR BetreuerIn
|0 (DE-588)1025112261
|0 (DE-627)751682756
|0 (DE-576)170797481
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 856 |
4 |
2 |
|u https://www.gbv.de/dms/tib-ub-hannover/1801100403.pdf
|m V:DE-601
|m B:DE-89
|q pdf/application
|v 2023-07-21
|3 Inhaltsverzeichnis
|
| 936 |
b |
k |
|a 44.41
|j Pharmazeutische Biologie
|0 (DE-627)181571781
|
| 951 |
|
|
|a BO
|
| 990 |
|
|
|a Coenzym
|
| 990 |
|
|
|a Arzneimittelentwicklung
|
| 992 |
|
|
|a 20220509
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2022
|
| 998 |
|
|
|g 125695120X
|a Löcherer, Christian
|m 125695120X:Löcherer, Christian
|d 140000
|d 140001
|e 140000PL125695120X
|e 140001PL125695120X
|k 0/140000/
|k 1/140000/140001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1801100403
|e 4130364316
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"recId":"1801100403","person":[{"given":"Christian","family":"Löcherer","display":"Löcherer, Christian","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Andres","role":"dgs","roleDisplay":"AkademischeR BetreuerIn","family":"Jäschke","display":"Jäschke, Andres"}],"id":{"eki":["1801100403"]},"note":["References: Seite 132-141"],"corporate":[{"display":"Universität Heidelberg","role":"dgg","roleDisplay":"Grad-verleihende Institution"}],"title":[{"title":"CoA precursors and their analogs for the treatment of genetic disorders and as 5´-end modification of RNA","title_sort":"CoA precursors and their analogs for the treatment of genetic disorders and as 5´-end modification of RNA"}],"name":{"displayForm":["presented by Apotheker Christian Löcherer ; referees: Prof. Dr. Andres Jäschke, Prof. Dr. Dr. Stoecklin"]},"language":["eng"],"noteThesis":["Dissertation. - Ruprecht-Karls-University Heidelberg. - 2022"],"type":{"bibl":"thesis"},"origin":[{"publisherPlace":"Heidelberg","dateIssuedKey":"2022","dateIssuedDisp":"[2022]"}],"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"[12], 146 Seiten"}]}
|
| SRT |
|
|
|a LOECHERERCCOAPRECURS2022
|
